Alcohol Addiction – Global Clinical Trials Review, 2022
The alcohol addiction clinical trial report provides a comprehensive overview of trials count and their average enrollment in top countries conducted globally. The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based on number of ongoing trials).
What are the market dynamics in the alcohol addiction clinical trials market?
Alcohol addiction clinical trial report consists of more than 800 trials. Trials conducted by companies are in Phase IV, Phase III, Phase II, Phase I and Phase 0. Similarly, the trials with different status compile of completed, ongoing, planned, suspended, terminated and withdrawn.
Which are the key regions in the alcohol addiction clinical trials market?
The key regions in the alcohol addiction clinical trials market are Asia-Pacific, Europe, North America, Middle East & Africa, and South & Central America.
Alcohol addiction clinical trials market in Asia-Pacific
The top five countries in Asia-Pacific in the alcohol addiction clinical trials market are China, South Korea, India, Australia, and Japan. Australia has the highest number of clinical trials, followed by India, China, Japan, and South Korea.
Alcohol addiction clinical trials market in Europe
The top five countries in Europe in the alcohol addiction clinical trials market are Russia, Germany, the United Kingdom, Spain, and France. Germany has the highest number of clinical trials, followed by France, Russia, the UK, and Spain.
Alcohol addiction clinical trials market in North America
The top two countries in North America in the alcohol addiction clinical trials market are the US and Canada. The US has the highest number of clinical trials followed by Canada.
Alcohol addiction clinical trials market in the Middle East & Africa
The top five countries in the Middle East & Africa in the alcohol addiction clinical trials market are Iran, Israel, Lebanon, South Africa, and Uganda. Iran has the highest number of clinical trials, followed by Israel, Lebanon, South Africa, and Uganda.
Alcohol addiction clinical trials market in South & Central America
The top two countries in South & Central America in the alcohol addiction clinical trials market are Brazil and Peru. Brazil has the highest number of clinical trials followed by Peru.
Alcohol addiction clinical trials market in G7 countries
The G7 countries in the alcohol addiction clinical trials market include the US, the UK, Germany, France, Italy, Canada and Japan. The US have the highest number of alcohol addiction clinical trials as of February 2022
Alcohol addiction clinical trials market in E7 countries
The E7 countries in the alcohol addiction clinical trials market include Brazil, Russia, India, China, Mexico, Turkey and Indonesia. Russia has the highest number of alcohol addiction clinical trials as of February 2022.
Alcohol addiction clinical trial market, by key region
For more regional insights, download a free sample
Which are the key sponsors in the alcohol addiction clinical trials market?
The key sponsors in the alcohol addiction clinical trials market are Alkermes Plc, The Lundbeck Foundation, Pfizer Inc, Johnson & Johnson, Eli Lilly and Co, Otsuka Holdings Co Ltd, Merck & Co Inc, Indivior Plc, GlaxoSmithKline Plc, and AstraZeneca Plc.
Alcohol addiction clinical trial market, by key sponsors
To know more about key sponsors, download a free sample
Market report scope
| Key regions | Asia-Pacific, Europe, North America, Middle East & Africa, and South & Central America |
| Key phases | Phase IV, Phase III/IV, Phase III, Phase II/III, Phase II, Phase I/II, Phase I, and Phase 0 |
| Key sponsors | Alkermes Plc, The Lundbeck Foundation, Pfizer Inc, Johnson & Johnson, Eli Lilly and Co, Otsuka Holdings Co Ltd, Merck & Co Inc, Indivior Plc, GlaxoSmithKline Plc, and AstraZeneca Plc. |
Scope
- The report provides a snapshot of the global clinical trials landscape.
- Report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end point status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with the reason for failure.
- The report provides enrollment trends for the past five years.
- Report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Key Players
Table of Contents
List of Tables
List of Figures
Frequently Asked Questions
Asia-Pacific, Europe, North America, Middle East & Africa, and South & Central America are the key regions in the alcohol addiction clinical trials market.
The key phases in the alcohol addiction clinical trials market are Phase IV, Phase III/IV, Phase III, Phase II/III, Phase II, Phase I/II, Phase I, and Phase 0.
Alkermes Plc, The Lundbeck Foundation, Pfizer Inc, Johnson & Johnson, Eli Lilly and Co, Otsuka Holdings Co Ltd, Merck & Co Inc, Indivior Plc, GlaxoSmithKline Plc, and AstraZeneca Plc. are the key sponsors in the alcohol addiction clinical trials market.
Get in touch to find out about our multi-purchase discounts
reportstore@globaldata.com
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
Testimonial
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Related reports
View more Central Nervous System reports